Related Experiment Video
Updated: Feb 20, 2026
07:24
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
2.0K
Red cell genotyping precision medicine: a conference summary
Gregory A Denomme1, Waseem Q Anani2, Neil D Avent3
1Diagnostic Laboratories, BloodCenter of Wisconsin, 638 N 18th Street, PO Box 2178, Milwaukee, WI 53201-2178, USA.
Therapeutic Advances in Hematology
|October 21, 2017
Summary
Red cell genotyping advances molecular immunohematology, improving patient care and preventing alloimmunization. This precision medicine approach offers future transfusion strategies.
Area of Science:
- Molecular Immunohematology
- Transfusion Medicine
- Precision Medicine
Background:
- The 6th annual Red Cell Genotyping symposium convened in 2015.
- Focus was on molecular immunohematology's impact on patient care.
Purpose of the Study:
- Discuss advances in molecular immunohematology for patient care.
- Present case reports illustrating patient care strategies.
- Review molecular studies and their clinical implications.
- Identify red cell genotyping for alloimmunization prevention.
- Compare future red cell genotyping options in transfusion medicine.
Main Methods:
- Symposium summary of presented topics.
- Review of molecular immunohematology advancements.
- Case report analysis.
- Discussion of genotyping strategies.
Main Results:
- Molecular immunohematology is transforming patient care.
- Genotyping strategies can prevent red blood cell alloimmunization.
- Current molecular studies have direct clinical practice implications.
Conclusions:
- Red cell genotyping is a key component of precision transfusion medicine.
- The symposium highlighted the state of the art in red cell genotyping.
- Future applications promise enhanced patient outcomes through personalized transfusion strategies.
